Opioid Addiction

Latest

Scope-of-Practice Restrictions Affect Buprenorphine Waivers for OUD

By

Michelle Lampariello

State scope-of-practice laws impact the ability of nurse practitioners to prescribe medication-assisted treatment for patients with opioid use disorder.

IV Tramadol Not Approved Due to Potential Safety Concern

By

Brian Park, PharmD

The FDA stated that IV tramadol is not safe for the intended patient population.

Role of Intravenous Acetaminophen in Reducing Opioid Consumption After Surgery

By

Amit Akirov, MD

IV acetaminophen is approved for the management of moderate to severe pain with adjunctive opioid analgesics, but limited data are available on the opioid-sparing effect of IV acetaminophen after surgical interventions.

ASA: Sustained Decrease Seen in Prescription Opioid Abuse

Prescription pain medication abuse decreased significantly from 2007 to 2018.

CDC Reports Increase in Drug Overdose Involving Cocaine From 2013 to 2018

From 2013 to 2018, the rate of drug overdose deaths involving cocaine increased nearly threefold.

Assessing the Impact of Opioid Restrictions on Institutional Opioid Utilization

By

Amit Akirov, MD

Restrictions on intravenous opioid products at an academic medical institution during a critical drug shortage were not found to have significant impact on overall institutional opioid utilization.

Potential Danger for Drug Interactions With Dental Opioid Prescribing

Opioids prescribed by dentists may pose a threat for interactions with medications for depression or anxiety in older adults.

Previously FDA-Approved Opioid Products Did Not Have Adequate Safety Assessment

By

Jessica Nye, PhD

Opioid products approved by the FDA between 1997 and 2018 relied on short- or intermediate-term studies that did not adequately analyze safety outcomes.

Long-Term Infective Endocarditis Risk in People Who Inject Opioids

By

Bradley van Paridon

Researchers developed a microsimulation model of the natural history of injection opioid use to assess long-term infective endocarditis mortality associated with injection opioid use in the United States.

Longer Drive Times to Opioid Treatment Programs May Limit Methadone Access in United States

By

Morgan E. Meissner

Driving times to opioid treatment programs is longer than driving time to pharmacies, which may restrict access to methadone treatment.